| 2021 | Dicerna Pharmaceuticals Coverage Dropped by Chardan After Novo Nordisk Closes Acquisiti.. | MT |
| 2021 | Chardan Drops Coverage on Neutral-Rated Dicerna Pharmaceuticals on Acquisition by Novo .. | MT |
| 2021 | Dicerna Pharmaceuticals, Inc.(NasdaqGS:DRNA) droppe.. | CI |
| 2021 | Dicerna Pharmaceuticals, Inc.(NasdaqGS:DRNA) droppe.. | CI |
| 2021 | Dicerna Pharmaceuticals, Inc.(NasdaqGS:DRNA) droppe.. | CI |
| 2021 | Novo Nordisk Completes Dicerna Pharmaceuticals Acquisition | MT |
| 2021 | Dicerna Pharmaceuticals : Novo Nordisk Announces Completion of Dicerna Pharmaceuticals Acq.. | PU |
| 2021 | Novo Nordisk Closes on $3.3 Billion Acquisition of Dicerna Pharmaceuticals | MT |
| 2021 | Novo Nordisk Announces Completion of Dicerna Pharmaceuticals Acquisition | BU |
| 2021 | Dicerna Pharmaceuticals, Inc.(NasdaqGS:DRNA) droppe.. | CI |
| 2021 | Novo Nordisk A/S (CPSE:NOVO B) completed the acquisition of remai.. | CI |
| 2021 | Dicerna Announces Expiration of Hart-Scott-Rodino Act Waiting Period for Novo Nordisk T.. | BU |
| 2021 | Dicerna Pharmaceuticals, Inc.(NasdaqGS:DRNA) droppe.. | CI |
| 2021 | Chardan Downgrades Dicerna Pharmaceuticals to Neutral Rating From Buy on Proposed Acqui.. | MT |
| 2021 | Chardan Downgrades Dicerna Pharmaceuticals to Neutral From Buy, Adjusts Price Target to.. | MT |
| 2021 | Insider Sell: Dicerna Pharmaceuticals | MT |
| 2021 | Stifel Downgrades Dicerna Pharmaceuticals to Hold From Buy, Adjusts Price Target to $38.. | MT |
| 2021 | Alnylam Pharmaceuticals Upgraded to Outperform From Sector Perform by RBC After R&D Day.. | MT |
| 2021 | North American Morning Briefing : Stock Futures -3- | DJ |
| 2021 | B. Riley Downgrades Dicerna Pharmaceuticals to Neutral from Buy After Announcing $3.3 B.. | MT |
| 2021 | RBC Downgrades Dicerna Pharmaceuticals to Sector Perform From Outperform, Lifts PT to $.. | MT |
| 2021 | HC Wainwright Downgrades Dicerna Pharmaceuticals to Neutral From Buy, Adjusts PT to $38.. | MT |
| 2021 | Health Care Stocks Ending Little Changed in Quiet Trading | MT |
| 2021 | Health Care Stocks Weakening This Afternoon | MT |
| 2021 | Sector Update: Health Care | MT |
| 2021 | Dicerna Shares Soar on Takeover by Novo Nordisk | DJ |
| 2021 | Wall Street Set for Positive Open as Upbeat Nvidia Earnings Buoy Sentiment | MT |
| 2021 | Health Care Stocks Edge Higher Premarket Thursday | MT |
| 2021 | Sector Update: Health Care | MT |
| 2021 | Dicerna Pharmaceuticals : Novo Nordisk to Acquire Dicerna - Form 8-K | PU |
| 2021 | Top Premarket Gainers | MT |
| 2021 | Novo Nordisk To Acquire Dicerna Pharmaceuticals | MT |
| 2021 | Dicerna Pharmaceuticals Enters $3.3 Billion Deal to Be Acquired by Novo Nordisk | MT |
| 2021 | Novo Nordisk to Buy Dicerna for $38.25 a Share | DJ |
| 2021 | Novo Nordisk to Acquire Dicerna | BU |
| 2021 | Novo Nordisk A/S (CPSE:NOVO B) entered into a definitive merger a.. | CI |
| 2021 | Dicerna Pharmaceuticals to Receive Multimillion-Dollar Milestone Payments Under Collabo.. | MT |
| 2021 | Dicerna Pharma : Two Targets in Lilly Collaboration Meet Proof of Princip.. | DJ |
| 2021 | Dicerna Announces Two Targets Meet Preclinical Proof of Principle Criteria in Neurodege.. | BU |
| 2021 | Dicerna Pharmaceuticals, Inc. Announces Two Targets Meet Preclinical Proof of Principle.. | CI |
| 2021 | Dicerna Presents Data From Phase 1 Trial of Belcesiran at American Association for the .. | BU |
| 2021 | Dicerna Pharmaceuticals, Inc. Presents Data from Phase 1 Trial of Belcesiran At America.. | CI |
| 2021 | Dicerna Pharmaceuticals Narrows Q3 Net Loss as Revenue Rises | MT |
| 2021 | Transcript : Dicerna Pharmaceuticals, Inc., Q3 2021 Earnings Call, Nov 09, 20.. | CI |
| 2021 | Dicerna Announces Third Quarter 2021 Financial Results and Provides a Business Update -.. | PU |
| 2021 | Dicerna Pharmaceuticals : Q3 Earnings Snapshot | AQ |
| 2021 | Earnings Flash (DRNA) DICERNA PHARMACEUTICALS Posts Q3 Revenue $63M, vs. Street Est of .. | MT |
| 2021 | Dicerna Announces Third Quarter 2021 Financial Results and Provides a Business Update | BU |
| 2021 | Dicerna Presents PHYOX2 and Primary Hyperoxaluria Healthcare Utilization Data at Americ.. | AQ |
| 2021 | Dicerna Presents PHYOX™2 and Primary Hyperoxaluria Healthcare Utilization Data a.. | BU |
| 2021 | Dicerna Pharmaceuticals, Inc. Presents PHYOX?2 and Primary Hyperoxaluria Healthcare Uti.. | CI |
| 2021 | Dicerna to Report Third Quarter 2021 Financial Results on Nov. 9, 2021 | BU |
| 2021 | Dicerna Pharmaceuticals : Announces Results for PHYOX4, Single-Dose Study of Nedosiran in .. | AQ |
| 2021 | Dicerna Pharmaceuticals : Says Hyperoxaluria Treatment Met Safet.. | MT |
| 2021 | Dicerna Pharmaceuticals : Announces Results for PHYOX™4, Single-Dose Study of Nedosi.. | BU |
| 2021 | Dicerna Announces Results for PHYOX™4, Single-Dose Study of Nedosiran in Primary Hypero.. | CI |
| 2021 | Dicerna Pharmaceuticals : Announces Data to Be Presented at American Society of Nephrology.. | BU |
| 2021 | Dicerna Pharmaceuticals : to Present Phase 1 Data for Two Drug C.. | MT |
| 2021 | Dicerna Pharmaceuticals : Announces Poster Presentations at American Association for the S.. | BU |
| 2021 | Dicerna Pharmaceuticals, Inc. Announces Poster Presentations at American Association fo.. | CI |
| 2021 | Dicerna Pharmaceuticals : Corporate Overview | PU |
| 2021 | Dicerna Pharmaceuticals : Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | BU |
| 2021 | Dicerna Pharmaceuticals : Initiates Phase 1 Clinical Trial of DCR-AUD, a Novel Investigati.. | AQ |
| 2021 | Dicerna Pharmaceuticals : Begins Early-Stage Trial of Potential .. | MT |
| 2021 | Dicerna Pharmaceuticals : Initiates Phase 1 Clinical Trial of DCR-AUD, a Novel Investigati.. | BU |
| 2021 | Dicerna Pharmaceuticals, Inc. Initiates Phase 1 Clinical Trial of DCR-AUD | CI |
| 2021 | Dicerna Pharmaceuticals : Names Rob Ciappenelli Chief Strategy O.. | MT |
| 2021 | Dicerna Pharmaceuticals : Announces New Executive Leadership Appointments | BU |
| 2021 | Dicerna Pharmaceuticals, Inc. Announces Executive Appointments | CI |
| 2021 | Insider Sell: Dicerna Pharmaceuticals | MT |
| 2021 | Transcript : Dicerna Pharmaceuticals, Inc. Presents at Citi’s 16th Annua.. | CI |
| 2021 | Dicerna Pharmaceuticals : Corporate Overview | PU |
| 2021 | Dicerna Pharmaceuticals : to Participate in 16th Annual Citi Biopharma Conference | BU |
| 2021 | Dicerna Pharmaceuticals : Corporate Overview | PU |
| 2021 | North American Morning Briefing: Stock Futures -3- | DJ |
Google
Twitter
Facebook
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
